Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Extended-spectrum beta-lactamases: epidemiology, detection, and treatment.
Nathisuwan S, Burgess DS, Lewis JS 2nd. Nathisuwan S, et al. Pharmacotherapy. 2001 Aug;21(8):920-8. doi: 10.1592/phco.21.11.920.34529. Pharmacotherapy. 2001. PMID: 11718498 Review.
Polymyxin B Etest® compared with gold-standard broth microdilution in carbapenem-resistant Enterobacteriaceae exhibiting a wide range of polymyxin B MICs.
Kulengowski B, Ribes JA, Burgess DS. Kulengowski B, et al. Clin Microbiol Infect. 2019 Jan;25(1):92-95. doi: 10.1016/j.cmi.2018.04.008. Epub 2018 Apr 16. Clin Microbiol Infect. 2019. PMID: 29674129
Continuous infusion beta-lactams for intensive care unit pulmonary infections.
Frei CR, Burgess DS. Frei CR, et al. Clin Microbiol Infect. 2005 May;11(5):418-21. doi: 10.1111/j.1469-0691.2005.01106.x. Clin Microbiol Infect. 2005. PMID: 15819874
A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology.
Burgess DS, Hastings RW. Burgess DS, et al. Diagn Microbiol Infect Dis. 2000 Oct;38(2):87-93. doi: 10.1016/s0732-8893(00)00173-5. Diagn Microbiol Infect Dis. 2000. PMID: 11035239
Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans.
Burgess DS, Hastings RW, Summers KK, Hardin TC, Rinaldi MG. Burgess DS, et al. Diagn Microbiol Infect Dis. 2000 Jan;36(1):13-8. doi: 10.1016/s0732-8893(99)00097-8. Diagn Microbiol Infect Dis. 2000. PMID: 10744363
77 results
Jump to page
Feedback